) and oncogenic KRAS G12D (KRAS G12D ) and stably selected with puromycin. Cells were either plated in 96 well plates for two days (HEK 293) before assay or released with enzyme free cell dissociation buffer and plated in 96 well plates in suspension for the assay (293T). Cells were either mock treated or treated with aprotinin (Ap) (2.2 μM), ϵ-ACA (100 mM) as indicated. The cells were washed 3 times with incubation buffer (Hanks balanced salt solution containing 3 mM CaCl 2 and 1 mM MgCl 2 ) and incubated with 0.5 µM glu-plasminogen for 20-30 minutes with or without aprotinin and ϵ-ACA before the addition of 500 µM plasmin substrate S2251 (Chromogenix, Diapharma Group). The rate of plasmin generation was determined from the slope of the A405nm vs time progress curve (N = 4). Statistical analysis was performed by two-way ANOVA.
Supplementary Figure S2: RAS activity in RAS expressing HEK 293 cells. HEK 293 cells stably expressing oncogenic HRAS
G12V (HRAS G12V ) and oncogenic KRAS G12D (KRAS G12D ) and empty vector (pBabe control) were plated, lysed and Ras/Raf pull down was carried as per the manufacturer's instructions (Millipore). GTP and GDP loaded empty vector cell lysates were used as positive and negative control for the pull down. 3 cells per well of a 96 well plate for plasmin generation assay. The cells were induced with 2 μg/ml of doxycycline while plating and were induced every subsequent day. Four days after induction, the cells were lysed in lysis buffer and protein content determined using the Bradford assay. (A) The total protein (20-30 ug) was separated using 10-20% gradient gel, followed by transfer to a nitrocellulose membrane. The membrane was probed with primary antibodies as indicated and subsequently probed with IRdye conjugated secondary antibodies and scanned using Li-COR Odyssey imager. The band intensities were quantified using the software from Li-COR. (B) For plasmin generation assay, cells were either mock treated or treated with aprotinin (Ap) (2.2 μM), ϵ-ACA (100 mM) as indicated. The cells were washed 3 times with incubation buffer (Hanks balanced salt solution containing 3 mM CaCl 2 and 1 mM MgCl 2 ) and incubated with 0.5 µM glu-plasminogen for 20-30 minutes with or without aprotinin and ϵ-ACA followed by the addition of 500 µM plasmin substrate S2251 (Chromogenix, Diapharma Group). The rate of plasmin generation was determined from the slope of the A 405 nm vs time 2 progress curve (N = 4). Statistical analysis was performed by Student t-test.
